Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Schering-Plough selects Corvas thrombin inhibitor for development

Jan. 13, 1997

NO donors claimed by Searle for cardiovascular applications

Jan. 13, 1997

Fibrinogen receptor antagonists under development at E. Merck

Jan. 10, 1997

Thrombin-binding anticoagulant disclosed by Japanese scientists

Jan. 10, 1997

Boehringer Mannheim clot-busting drug introduced in first market

Jan. 7, 1997

Thrombolytic agent introduced in Germany

Dec. 31, 1996

BMS describes thrombin-activatable plasminogen activator

Dec. 31, 1996

Novel thrombin inhibitors in development at LG Chemical

Dec. 31, 1996

Fujisawa discloses antiplatelet agents

Dec. 24, 1996

New antiplatelet drugs from Takeda

Dec. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...